UnitedHealth Group Incorporated (NYSE:UNH) Position Trimmed by Altus Wealth Group LLC

Altus Wealth Group LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.1% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 871 shares of the healthcare conglomerate’s stock after selling 37 shares during the period. Altus Wealth Group LLC’s holdings in UnitedHealth Group were worth $441,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Glenview Trust co grew its stake in UnitedHealth Group by 3.7% in the fourth quarter. Glenview Trust co now owns 49,572 shares of the healthcare conglomerate’s stock valued at $25,076,000 after purchasing an additional 1,776 shares in the last quarter. Patten & Patten Inc. TN grew its stake in shares of UnitedHealth Group by 2.2% in the 4th quarter. Patten & Patten Inc. TN now owns 40,277 shares of the healthcare conglomerate’s stock valued at $20,375,000 after buying an additional 870 shares in the last quarter. Facet Wealth Inc. raised its position in UnitedHealth Group by 48.8% during the fourth quarter. Facet Wealth Inc. now owns 1,547 shares of the healthcare conglomerate’s stock valued at $815,000 after acquiring an additional 507 shares in the last quarter. Sovereign Investment Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $352,000. Finally, Harbour Investments Inc. lifted its stake in shares of UnitedHealth Group by 3.1% in the 4th quarter. Harbour Investments Inc. now owns 6,802 shares of the healthcare conglomerate’s stock valued at $3,441,000 after purchasing an additional 203 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. KeyCorp reiterated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Oppenheimer increased their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Finally, Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Price Performance

NYSE:UNH opened at $488.52 on Friday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market capitalization of $446.85 billion, a price-to-earnings ratio of 31.52, a PEG ratio of 1.37 and a beta of 0.62. The company has a 50-day moving average of $511.36 and a 200-day moving average of $550.07.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the firm posted $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.72%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.